What Trump's generic drug tariffs could mean, according to experts
ONP Summary
Trump announced a phased tariff plan on imported generic drugs with 0% duties for two years starting August 1, 2026, escalating to 100% by August 2028. Concurrently, he plans tariffs of 10–12.5% on 60+ trading partners to replace an expiring 10% global levy, citing alleged forced labor violations.
Progressive:Protectionist unilateralism — Progressive outlets emphasize Trump's unilateral tariff decisions and their impact on established suppliers like India.
Moderate:Labor-focused tariff shift — Moderate outlets present the tariffs as restructuring trade rules in response to alleged forced labor violations.
Conservative:Domestic production incentive — Conservative outlets highlight the tariffs as strategy to restore pharmaceutical manufacturing within the US.
Health policy experts say higher import duties could increase costs and strain supplies while offering no guarantee manufacturers will shift production to the U.S. ...
이 뉴스, 어떠셨어요?
탭 한 번으로 반응 · 로그인 불필요